Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn Keil

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Transfusion|April 9, 2010
Defining "adequate" pathogen reduction performance for transfused blood componentsRaymond P Goodrich, Brian Custer, Shawn Keil, et al.
Blood Transfusion = Trasfusione Del Sangue|July 1, 2017
Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technologySusan Yonemura, Suzann Doane, Shawn Keil, et al.
Transplantation|November 14, 2007
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplantsHiroshi Asano, Chih-Yuan Lee, Karen Fox-Talbot, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Transfusion|April 9, 2010
Defining "adequate" pathogen reduction performance for transfused blood componentsRaymond P Goodrich, Brian Custer, Shawn Keil, et al.
Blood Transfusion = Trasfusione Del Sangue|July 1, 2017
Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technologySusan Yonemura, Suzann Doane, Shawn Keil, et al.
Transplantation|November 14, 2007
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplantsHiroshi Asano, Chih-Yuan Lee, Karen Fox-Talbot, et al.
Pageof 1